Echo Street Capital Management LLC Seagen Inc. Transaction History

Echo Street Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $15,962 - $18,927	-136 Reduced 2.07%	6,447 $828,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $890,482 - $1.19 Million	6,583 New	6,583 $901,000
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $556,345 - $916,914	-5,113 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $247,592 - $326,749	2,070 Added 68.02%	5,113 $737,000
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $433,840 - $580,786	3,043 New	3,043 $470,000
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $705,269 - $840,778	-4,951 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $208,158 - $248,255	-1,541 Reduced 23.74%	4,951 $782,000
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $892,714 - $1.24 Million	6,492 New	6,492 $901,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.